• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Twist Your Tastebuds Three Ways: Good Supply Cannabis Brand Launches 'Twisted' All-In-One Vapes

    5/30/24 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $TLRY alert in real time by email

    TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced the highly anticipated Good Supply® ‘Twisted' All-In-One ("AIO") Vapes hitting the market, offering a revolutionary way to experience its delicious vape flavours. With the ability to switch between complimentary flavours or combining them for a "twist" – creating a unique third flavour experience of the two flavours enjoyed together, Good Supply has a jam packed vape with a series of unique flavour possibilities all-in-one, ready to go for consumers looking for variety that packs a punch.

    With the new Twisted All-in-One vape, consumers can select from three mouthwatering combinations:

    • Purple Monkey & Frozen Watermelon: The grape goodness of Purple Monkey and the refreshing fruity coolness of Frozen Watermelon collide in a category-five flavour storm, available in 2 x 0.6g.
    • Orange Swirl & Strawberry Freeze: The indulgent creamy citrusy flavours of Orange Swirl and the fresh juicy cooling experience of Strawberry Freeze combine to create a blend of citrus, fruity and vanilla goodness available in 2 x 0.6g.
    • Mango Passionfruit & Guava Sunrise: Launching later this summer to join the collection, this additional vape features a blend of Mango Passionfruit and Guava Sunrise, featuring the ultimate tropical tornado available in 2 x 0.6g.

    Each Twisted vape is filled to the brim with 1.2g of flavoured distillate for a potent total 1,000mg of THC, delivering a satisfying experience with every puff. The rechargeable battery provides long-lasting enjoyment, allowing users to savour every last drop of flavor. Consumers can mix and match two fantastic flavours or combine them into a unique twist for a customized vaping experience.

    Quick recap on the product details:

    • Single Flavours or Twisted: Consumers can easily switch between primary flavours of this 1.2g vape that can be enjoyed on their own or combine them for a third unique blend with the push of a button.
    • Charged Up: Rechargeable battery ensures maximum usage and lessens environmental footprint of wasted devices.
    • Green You Can Feel Good About: Over 131,000kg of plastic diverted from landfills annually from the use of Good Supply's hemp tube packaging across its products, plus reforestation efforts through Printreleaf™ partnership.

    Disclaimer: Twisted vapes are intended for adult use only. Please consume responsibly and in accordance with local regulations.

    Good Supply's Twisted AIO vapes redefine the convenience of their consumer vaping experience while supporting the minimization of repurchases to help to reduce waste across the Canadian cannabis market. Embracing the mindset of ‘Green You Can Feel Good About', and as part of their larger "Feel Good Highs" strategy, Good Supply consistently re-enforces the notion that consumers can feel good about every aspect of their cannabis purchase, from the product to the packaging that comes with it.

    TWISTED All-in-One vapes will be available across Canada starting this summer. For more information on where to find Good Supply, check out www.goodsupplycannabis.com.

    About Good Supply

    Good Supply is one of Canada's leading cannabis brands and has been recognized as #1 in flower, and best-selling pre-rolls, vapes, and concentrates, and has become a favourite among consumers and budtenders. At Good Supply, good is the new great. Rooted in classic strains that punch above their weight, Good Supply delivers consistent, hard-hitting quality at affordable prices. Explore classic cannabis strains, innovative formats, and new flavours – we're always up for a good time.

    To learn more about Good Supply and its latest product launches, visit www.goodsupplycannabis.com and follow @goodsupplycannabis.

    About Tilray Brands

    Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with four distinct and complementary business segments including medical and adult-use cannabis, medical distribution, wellness foods, and beverage-alcohol. Tilray Brands is on a mission to change people's lives for the better – one person at a time - by inspiring and empowering the worldwide community to live their very best life, enhanced by moments of connection and wellbeing. Patients and consumers trust Tilray Brands to be the most responsible, trusted and market leading cannabis and consumer products company in the world with a portfolio of innovative, high-quality, and beloved brands that address the needs of the consumers, customers, and patients we serve. A pioneer in cannabis research, cultivation, and distribution, today Tilray Brands' unprecedented and diversified production platform supports a portfolio of best-in-class brands in over 20 countries including comprehensive adult-use and medical cannabis offerings, hemp-based foods, and craft beverages across North America, Europe, Australia, and Latin America.

    For more information on Tilray Brands, visit Tilray Brands, Inc. and follow @Tilray on Instagram, Twitter, Facebook, and LinkedIn.

    Forward-Looking Statements

    Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, "forward-looking statements") under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the "safe harbor" created by those sections and other applicable laws. Forward-looking statements can be identified by words such as "forecast," "future," "should," "could," "enable," "potential," "contemplate," "believe," "anticipate," "estimate," "plan," "expect," "intend," "may," "project," "will," "would" and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company's ability to commercialize new and innovative products worldwide and achieve listed sustainability forecasts. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

    Contacts:

    Tilray Media: [email protected]

    Investors: [email protected]



    Primary Logo

    Get the next $TLRY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TLRY

    DatePrice TargetRatingAnalyst
    4/5/2024$2.25 → $2.75Neutral
    Alliance Global Partners
    11/2/2022$3.90Mkt Perform
    Bernstein
    7/29/2022$3.00Hold → Sell
    The Benchmark Company
    3/4/2022$9.00Hold → Buy
    Canaccord Genuity
    1/11/2022$7.40 → $6.90Neutral
    Cantor Fitzgerald
    1/7/2022$11.80 → $7.40Neutral
    Cantor Fitzgerald
    11/18/2021$10.00Underweight
    Barclays
    11/1/2021$18.00 → $11.80Overweight → Neutral
    Cantor Fitzgerald
    More analyst ratings

    $TLRY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Merton Carl A bought $35,360 worth of shares (26,000 units at $1.36) (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      11/18/24 11:29:05 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Faltischek Denise M bought $20,500 worth of shares (10,000 units at $2.05), increasing direct ownership by 4% to 293,269 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/18/24 8:32:10 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Gendel Mitchell bought $14,256 worth of shares (7,200 units at $1.98), increasing direct ownership by 4% to 195,796 units (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/16/24 1:07:47 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    $TLRY
    Financials

    Live finance-specific insights

    See more
    • Tilray Brands Reports Q3 Fiscal 2025 Financial Results

      Tilray Confirms No Current Impact of Tariffs Generated Net Revenue of $186 Million in the Third Quarter, $193 Million in Constant Currency; Strategic Initiatives and SKU Rationalization Impacted Revenue by $13 Million Tilray Beverage Expands U.S. Distribution of Hemp-Derived THC Drinks Across 10 States, Increases Project 420 Cost Savings Plan to $33 Million Tilray Cannabis Increased Gross Margins by 800 bps, Remains the Leader in Canada by Sales Performance, and Generates Strong Sales Growth in Germany Strengthens Balance Sheet with Convertible Note Reduction of $58 Million and Total Debt Reduction of $71 Million, $248 Million Available in Cash and Marketable Securities NEW Y

      4/8/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025

      NEW YORK and LEAMINGTON, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced that the Company will release financial results for its third quarter fiscal 2025 ended February 28, 2025 before financial markets open on April 8, 2025. Live Conference Call and Audio Webcast Tilray will hold a live conference call, which will be webcast, to discuss these results at 8:30 a.m. Eastern Time. The webcast can be accessed in the Investors section of Tilray's website at www.Tilray.com. About Tilray Bran

      3/27/25 4:30:00 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Reports Q2 2025 Financial Results

      Gross Profit Increased by 29% Year-Over-Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net Revenue of $211 Million, 10% in Constant Currency Beverage Revenue Increase by 36%, International Cannabis by 25%, Wellness Segment by 13% Announces Project 420: A $25 Million Synergy Plan for Tilray Beverage Business Tilray Reaffirms Fiscal Year 2025 Guidance Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods co

      1/10/25 7:00:50 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    $TLRY
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $TLRY
    SEC Filings

    See more

    $TLRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Shock Top: A Bold Rebrand for a Craft Beer Icon

      PORTLAND, Ore., May 08, 2025 (GLOBE NEWSWIRE) -- Shock Top, a craft beer icon and brand by Tilray Brands, Inc. company (NASDAQ:TLRY, TSX:TLRY), known for its bold flavors and unfiltered wheat ales, today announced a transformative rebrand. With revamped packaging, a new logo, and an expanded, integrated marketing campaign, Shock Top aims to shock a new generation of beer drinkers with a modern look and shocking new seasonal flavors. Building on its legacy of delivering exceptional beers, Shock Top's rebrand introduces a completely new visual identity that enhances its personality and offers a unique experience with every flavor. The new Wedgehead icon is designed as a bolder and more cont

      5/8/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Blue Point Brewing Co. Announces the Return of Delayed Pilsner

      PATCHOGUE, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Blue Point Brewing Co., a Tilray Brands, Inc., (NASDAQ:TLRY, TSX:TLRY) craft beer brand, announces the highly anticipated re-release of Delayed Pilsner, a beer crafted to soothe the soul of every New Yorker facing the inevitable delays of city life. Whether it's 2 minutes or 2 hours, delays are scientifically proven to be the bane of any New Yorker's existence. But fear not, Blue Point Brewing has brewed the ultimate lager to get you through this abomination. Delayed Pilsner is brewed with a blend of floral, spicy hops that impart subtle apple and lemon-lime aromas. Balanced by slight honey notes from a creamy malt body, the result is a

      5/6/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • 10 Barrel Brewing Launches Non-Alcoholic Apocalypse IPA, a Bold Craft Brew for Your Next Adventure

      BEND, Ore., April 30, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing, a Tilray Brands, Inc., (NASDAQ:TLRY, TSX:TLRY) craft beer brand, is excited to announce the launch of NA Apocalypse IPA, a non-alcoholic version of their beloved Apocalypse IPA. This new offering delivers the same bold, hop-driven flavor that fans have come to love, now without the alcohol. NA Apocalypse IPA is crafted with the same big flavor to provide the signature punch of pine, citrus, and tropical notes that define the original IPA, minus the alcohol. Whether you're winding down at the end of the day or gearing up for a new adventure, NA Apocalypse IPA offers a taste that's big on hops and light on compromise. "We

      4/30/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form DEFA14A filed by Tilray Brands Inc.

      DEFA14A - Tilray Brands, Inc. (0001731348) (Filer)

      4/28/25 4:55:34 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form DEF 14A filed by Tilray Brands Inc.

      DEF 14A - Tilray Brands, Inc. (0001731348) (Filer)

      4/28/25 4:53:44 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray Brands Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

      8-K - Tilray Brands, Inc. (0001731348) (Filer)

      4/25/25 4:06:00 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 4 filed by Director Cohen Steven Michael

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      1/8/25 4:16:07 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • New insider Cohen Steven Michael claimed no ownership of stock in the company (SEC Form 3)

      3 - Tilray Brands, Inc. (0001731348) (Issuer)

      12/17/24 4:05:56 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Chief Financial Officer Merton Carl A bought $35,360 worth of shares (26,000 units at $1.36) (SEC Form 4)

      4 - Tilray Brands, Inc. (0001731348) (Issuer)

      11/18/24 11:29:05 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    $TLRY
    Leadership Updates

    Live Leadership Updates

    See more
    • Terrapin Beer Co. Celebrates 20 Years of Iconic Wake-n-Bake Beer with Exciting Wake-n-Bake Off Event in Athens, GA

      ATHENS, Ga., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer Co., a Tilray Beverages craft beer brand under Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is excited to announce the 20th anniversary of its Wake-n-Bake Coffee Oatmeal Imperial Stout seasonal beer and the annual Wake-n-Bake Off event on Sunday, January 26th, 2025, at the Terrapin taproom in Athens, GA. In celebration of its 20th anniversary, guests will have the chance to observe local restaurants competing to craft the finest dish featuring Terrapin's renowned Wake-n-Bake Beer. This event highlights culinary innovation and fosters community engagement through an array of sweet and savory tastings that showcase the rich flavor

      1/23/25 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Blue Point Brewing Launches Big Mo Brew to Raise Funds and Awareness for Men's Health During Movember

      PATCHOGUE, N.Y., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island's original craft brewery and subsidiary of Tilray Brands, (NASDAQ:TLRY, TSX:TLRY), is proud to announce the continuation of its men's health awareness campaign in support of Movember. The month shines a light on key men's health issues—mental health, prostate cancer, and testicular cancer—encouraging open conversations and proactive engagement. To honor the initiative, Blue Point Brewing announced the special release of its classic double IPA, Big Mo, available at our brewery and retailers in Long Island, New York. This hazy double IPA, featuring prominent mosaic hops and an ABV of 8.0%, proud

      10/22/24 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Breckenridge Brewery Opens New Location in Fort Collins, Colorado

      FORT COLLINS, Colo., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a Colorado-based craft brewer with over 30 years of experience brewing approachable, well-balanced beers, announces the opening of its new brewery location in Fort Collins. With doors opening in early August 2024, the new 10,000-square-foot Breckenridge Brewery offers a full restaurant experience and a new vibrant atmosphere in the heart of Fort Collins for all to enjoy. The new location will be a full-service restaurant, upholding the Breckenridge Brewery legacy while ushering in new opportunities for innovation and community collaboration. With a menu boasting a diverse range of culinary delights designed to co

      8/5/24 7:00:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    $TLRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Tilray Brands Inc. (Amendment)

      SC 13G/A - Tilray Brands, Inc. (0001731348) (Subject)

      2/13/23 1:34:44 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G filed by Tilray Brands Inc.

      SC 13G - Tilray Brands, Inc. (0001731348) (Subject)

      2/10/23 4:41:36 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D filed by Tilray Brands Inc.

      SC 13D - Tilray Brands, Inc. (0001731348) (Filed by)

      7/22/22 4:30:22 PM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care

    $TLRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Alliance Global Partners reiterated coverage on Tilray with a new price target

      Alliance Global Partners reiterated coverage of Tilray with a rating of Neutral and set a new price target of $2.75 from $2.25 previously

      4/5/24 7:39:50 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Bernstein initiated coverage on Tilray with a new price target

      Bernstein initiated coverage of Tilray with a rating of Mkt Perform and set a new price target of $3.90

      11/2/22 6:37:00 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care
    • Tilray downgraded by The Benchmark Company with a new price target

      The Benchmark Company downgraded Tilray from Hold to Sell and set a new price target of $3.00

      7/29/22 7:19:40 AM ET
      $TLRY
      Medicinal Chemicals and Botanical Products
      Health Care